Viva Biotech (1873.HK) Announces 2023 Annual Results: Succes

/PRNewswire/ -- Highlights of the Annual Results as of December 31, 2023: Revenue reached RMB2,155.6 million Gross profit amounted to RMB738.5 million Adjusted...

Related Keywords

France , Taiwan , Dubai , Dubayy , United Arab Emirates , Germany , Switzerland , Zhejiang , China , Chengdu , Sichuan , Australia , Suzhou , Jiangsu , Zhoupu , Hangzhou , Japan , Canada , Qiantang , Guangdong , United States , United Kingdom , Taizhou , Shanghai , Jiaxing , Chinese , America , Ningbo Nuobai , Chen Cheney Mao , Langhua Pharma , Investment Corporation Of Dubai , Viva Biotech Holdings , Shanghai Supercomputing Center , Temasek , Successful Exits Of Certain Incubation Portfolio Companies , Viva Biotech Holdings Group , Langhua Pharmaceuticals , Annual Results , Highlight Capital , True Light Capital , Investment Corporation , Reporting Period , Attractive Outlook , Long Run Despite Slight Fluctuation , Chinese Mainland , Langhua Pharmaceutical , Certain Incubation Portfolio Companies , Future Plans , Incubation Business , North America , Active Pharmaceutical Ingredient , Shanghai Supercomputing , Faladi Road , Qiantang New District , Supercomputing Center , Viva Biotech ,